Case Studies from across the Catapults
- Skills (11),
- Regional growth (18),
- Highlights (27),
- Equality, Diversity and Inclusion (12),
- International (12),
- Academic engagement (19),
- Net Zero (23),
- Health (18),
- Digital technologies (18),
- Business growth (29),
- Supply chains (6),
- Leveraging Investment (19),
Themes (Reset)
- Cross-Catapult (2),
- Cell and Gene Therapy (15),
- Compound Semiconductor Applications (13),
- Connected Places (14),
- Digital (15),
- Energy Systems (14),
- High Value Manufacturing (17),
- Medicines Discovery (14),
- Offshore Renewable Energy (15),
- Satellite Applications (14),
Catapults (Reset)
Cell and Gene Therapy
Case Study
Advancing acute myeloid leukaemia cell therapy
A collaboration between the Cell and Gene Therapy Catapult, University College London and Imperial College London advances a novel cell therapy for the treatment of acute myeloid leukaemia.
Cell and Gene Therapy
Case Study
Developing treatments for chronic kidney disease
University spin-out Purespring Therapeutics sought expert input from the Cell and Gene Therapy Catapult to efficiently progress their pre-clinical development plans and secured one of the largest single investment to a UK biotech company from global healthcare giant Syncona.
Cell and Gene Therapy
Case Study
Pioneering technology to increase effectiveness of gene therapeutics
A collaboration between the Cell and Gene Therapy Catapult and Synpromics set out to develop novel scalable manufacturing processes and technologies to produce viral vectors at scale.
Cell and Gene Therapy
Case Study
Enabling the development of potentially life-saving therapies
The emergence of cell therapies will potentially change the landscape of healthcare. The Cell and Gene Therapy Catapult, identified the need for a cell thawing system that would reduce barriers to the commercialisation.
Page 1 of 1